Urologists treating patients with suspicious ureteral or kidney lesions now have a tool to help them more effectively make diagnoses. Cook Medical has introduced the BIGopsy Backloading Biopsy Forceps, a device designed and engineered to obtain large renal or ureteral tissue specimens up to 4 mm3 for cancer diagnosis. The larger sample size helps produce biopsy results without the need for repeat tissue-sampling procedures associated with other biopsy devices.
Approximately 90 percent of renal cancers are transitional cell carcinomas (TCC), a common type of cancer that originates from transitional epithelial cells lining the urinary tract and affects a significant portion of the U.S. population. Early diagnosis of TCC is critical to successful treatment. However, diagnosis is often complicated by the small size of tissue samples obtained by current biopsy devices. Small tissue samples are more likely to deliver inconclusive results. Consequently, patients may need multiple procedures for accurate diagnosis, thereby adding to their anxiety, discomfort and costs.
Designed in collaboration with practicing endourologists, BIGopsy overcomes the issue of insufficient specimens for diagnosis by having a 4 mm3 biopsy cup, which is over four times larger than other biopsy forceps on the market. To accommodate the large cup size, BIGopsy has a removable, replaceable handle that allows it to be backloaded through the working channel of an endocscope.
For more information, visit www.cookmedical.com